General Information
Product name
Rituximab
CAS No.
174722-31-7
1.2.1 Relevant identified uses
- pharmaceutical active substance (antineoplastic)
Icons in SDS
Company Information
company name
F. Hoffmann-La Roche AG
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@roche.com
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
no classification and labelling according to CLP (EC Regulation 1272/2008) Note - no classification and labelling according to EU directives 67/548/EEC and 1999/45/EC
